1 – 2 of 2 jobs
Since over 170 years Pfizer colleagues from all over the world are working together to positively impact health for everyone, everywhere. Apart from marketing over 100 products in the Swiss market, the Pfizer AG commits itself
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Recommended jobs for you
